In the present study we have analyzed the HLA class II haplotypic and genotypic risk in Sardinian MS patients, with the specific aim to define whether trans-interactions between DRB1-DQB1 haplotypes concur in modifying the risk of the disease. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.